An enthusiasm for research and innovation is the foundation for Normon’s business strategy, enabling it to offer products and services that meet the expectation of patients and society in general.

The constant search for innovation made Normon the first company to enter the generics market in Spain. Since then, it has headed the Spanish sector for these medicinal products, both in terms of bioequivalence studies carried out and in the number of drug substances investigated.

Logically, Normon has obtained Good Laboratory Practices (GLP) certification in accordance with Directive 88/322 EEC, applicable to the development of new products. This ensures the quality and veracity of the studies performed.

The extension and modernisation of the facilities for the Pharmaceutical Development Department and the floor set aside for a new Basic Research
Plan represents a further step forward for our Company.

 

<< Previous

Next >>